When a Common Skin Bacterium Becomes Untreatable
Staphylococci are normal inhabitants of skin and mucous membranes in both humans and animals. In most circumstances they cause no harm. But when certain strains acquire resistance to methicillin — a broad-spectrum antibiotic used as a benchmark for resistance — the implications for treatment become serious. Methicillin-resistant Staphylococcus aureus (MRSA) and its canine counterpart methicillin-resistant Staphylococcus pseudintermedius (MRSP) are increasingly recognised in companion animals, raising questions about household transmission that every pet owner should understand.
MRSA Versus MRSP: Understanding the Difference
MRSA is primarily a human pathogen that can be transiently carried by pets, particularly dogs and cats with frequent veterinary contact or whose owners work in healthcare. Pets rarely become ill from MRSA themselves, but they can act as environmental reservoirs, reinfecting humans in the same household — a phenomenon known as the pet-human-pet transmission cycle.
MRSP, by contrast, is a veterinary pathogen. It is one of the most important causes of treatment-refractory skin, ear, and wound infections in dogs. While it occasionally colonises humans in contact with infected animals, it rarely causes clinical disease in immunocompetent people. However, it represents a serious challenge in veterinary medicine due to its extensive multi-drug resistance profile, often leaving only a handful of antibiotics effective.
How Pets Acquire Methicillin-Resistant Staphylococci
- Hospitalisation in veterinary clinics, where resistant strains circulate in the environment
- Repeated courses of antibiotics, which select for resistant strains over time
- Close contact with humans who carry MRSA, particularly healthcare workers
- Skin or wound infections that are inadequately treated, allowing resistant populations to dominate
- Contact with other colonised animals in kennels, groomers, or dog parks
Older animals, those with chronic skin conditions such as atopy, and those on long-term immunosuppressive medications are at greatest risk of developing clinical MRSP infections.
Clinical Signs in Dogs and Cats
Skin and Ear Infections
The most common presentation of MRSP in dogs is a pyoderma — a bacterial skin infection — that fails to respond to standard first-line antibiotics. Affected areas may show pustules, crusting, redness, and hair loss. Otitis externa caused by MRSP is particularly frustrating to manage and may persist for months despite multiple treatment attempts.
Wound and Post-Surgical Infections
Post-operative wound infections caused by methicillin-resistant Staphylococci represent a significant concern in veterinary surgery. Wounds that fail to heal, break down after initial closure, or produce persistent purulent discharge warrant culture and sensitivity testing as a priority.
Urinary Tract Infections
MRSP is an emerging cause of urinary tract infections in dogs, particularly those who have had catheters or repeated antibiotic courses for recurrent UTIs. Resistant urinary infections may require specialist input and cultures to identify effective treatment options.
Diagnosis and Treatment
Diagnosis requires bacterial culture and sensitivity testing from appropriate samples — skin swabs, ear swabs, or wound swabs depending on the site of infection. Your vet should not prescribe antibiotics for suspected Staphylococcal infections without culture results when resistance is suspected, as empirical treatment with ineffective antibiotics delays recovery and worsens resistance pressure.
Treatment options for MRSP are limited but may include chloramphenicol, rifampicin used in combination to prevent further resistance, fusidic acid for superficial skin infections, or specialist-guided use of drugs normally reserved for human medicine in severe cases. Always follow your vet's instructions precisely and complete the full course. Topical treatments — medicated shampoos, sprays, and ear preparations — play an important role and help reduce systemic antibiotic use.
Household Infection Control
When a Pet Is Colonised or Infected
- Wash hands thoroughly after handling the pet, its bedding, or any material from its enclosure
- Avoid allowing an infected pet to lick wounds, surgical sites, or broken skin on household members
- Wash pet bedding at 60°C or above at least twice weekly
- Clean frequently touched surfaces — sofas, floors, door handles — with appropriate household disinfectants
- Restrict the pet's access to bedrooms, particularly the beds of immunocompromised household members
For Healthcare Workers
If you work in a clinical environment and your pet has been diagnosed with MRSA colonisation, inform your occupational health department. The reverse is also relevant: if you test positive for MRSA as part of a healthcare screening programme, your pet may be a reinfection source and should be swabbed by your vet. Breaking the cycle requires decolonisation of all household members — human and animal — simultaneously.
Practical Summary
- Insist on culture and sensitivity testing before antibiotics are prescribed for skin, ear, or wound infections that have not responded to first-line treatment
- Complete every antibiotic course as directed — stopping early contributes to resistance
- Use topical treatments where appropriate to reduce the need for systemic antibiotics
- Maintain rigorous hand hygiene around infected pets
- Disinfect shared surfaces and wash bedding at high temperature regularly
- If MRSA is confirmed in a pet, discuss household decolonisation strategies with both your vet and your GP
Methicillin-resistant Staphylococcal infections are manageable with the right approach, but they demand careful diagnosis, judicious antibiotic use, and consistent household hygiene. Do not attempt to treat these infections without veterinary guidance — inappropriate antibiotic use is precisely how resistance emerges and spreads.